Immunovantincis A Clinical Stage Immunology Company Based In New Yorkwith Additional Operations In Switzerland And Bermudaas A Subsidiary Of Roivant Sciences Ltdimmunovant Is Focused On Developing Innovative Therapies For Autoimmune Diseasesaiming To Enhance The Quality Of Life For Affected Individuals The Company Specializes In Anti Fcrn Technology And Has A Promising Pipeline That Includes Batoclimabwhich Targets Conditions Such As Myasthenia Gravis And Thyroid Eye Diseaseand Mvt 1402Another Treatment For Autoimmune Diseasesimmunovant Is Actively Engaged In Clinical Trials To Advance Its Research And Development Efforts In This Field
United States
